WHO advises against Gilead's remdesivir for all hospitalised COVID-19 patients

 WHO advises against remdesivir

LONDON (Reuters) - Gilead’s remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they are, as there is no evidence the drug improves survival or reduces the need for ventilation, a World Health Organization panel said on Friday.

Komentarze

Popularne posty z tego bloga

Felaktig organisation grund till tragedin inom äldrevården

Socialstyrelsen publicerar en checklista för äldreboenden

Nie wiadomo jak wielu zmarłych miało bezpośredni kontakt z lekarzem